Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma.

Autor: Yousef, Sara1,2, Heise, Johanna3, Lajmi, Nesrine3, Bartels, Katrin3, Kröger, Nicolaus2, Luetkens, Tim1,3, Atanackovic, Djordje1,3,4 djordje.atanackovic@hci.utah.edu
Zdroj: Journal of Translational Medicine. 2015, Vol. 13 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate